Skip to main content
. 2021 Jul 1;12:694872. doi: 10.3389/fneur.2021.694872

Table 11.

Management of behavioral disturbances in PSP/CBS.

1. Pharmacologic management
    a. Apathy:
        i. Trial of modafinil or methylphenidate
    b. Impulsivity
        i. Behavioral approaches difficult because of frontal deficit.
        ii. Reduce levodopa and other dopaminergic medications
        iii. Trial of SSRI such as escitalopram or sertraline at standard dosages
        iv. Mood stabilizers such as valproic acid and lamotrigine
        v. ADHD drugs such as atomoxetine
    c. Depression/Mood disorder
        i Trial of SSRI at standard dosages
        ii Avoid tricyclic antidepressants due to side effects
    d. Pseudobulbar affect
        i. Trial of SSRI at standard dosages
        ii. Dextromethorphan-quinidine (second-line due to cost)
2. Non-pharmacologic management
    a. Caregiver/family education emphasizing that deficit is part of disease
    b. Occupational therapy
    c. Cognitive behavioral therapy
    d. Safety screening
        i. Risk of medication mismanagement,
        ii. Financial risk
        iii. Use of a stove
        iv. Driving
        v. Exposure to unsecured firearms